News Bronwyn Adams 10/10/24 Bronwyn Adams 10/10/24 Infensa researchers nominated for a national university award Read More Bronwyn Adams 7/10/24 Bronwyn Adams 7/10/24 Infensa drug candidate receives $17.8M funding to advance to clinical trials Read More Bronwyn Adams 30/8/24 Bronwyn Adams 30/8/24 Infensa wins KE Select Emerging Innovator of the Year at Life Sciences Queensland awards Read More Bronwyn Adams 30/7/24 Bronwyn Adams 30/7/24 Infensa Bioscience selected as a finalist for the 2024 KE Select Emerging Innovator Award by Life Sciences Queensland Read More Bronwyn Adams 23/5/24 Bronwyn Adams 23/5/24 Infensa CSO and co-founder Professor Glenn King elected a Fellow of the Australian Academy of Science Read More Bronwyn Adams 5/3/24 Bronwyn Adams 5/3/24 Brisbane startup Infensa spins medical miracle from spider venom Read More
Bronwyn Adams 10/10/24 Bronwyn Adams 10/10/24 Infensa researchers nominated for a national university award Read More
Bronwyn Adams 7/10/24 Bronwyn Adams 7/10/24 Infensa drug candidate receives $17.8M funding to advance to clinical trials Read More
Bronwyn Adams 30/8/24 Bronwyn Adams 30/8/24 Infensa wins KE Select Emerging Innovator of the Year at Life Sciences Queensland awards Read More
Bronwyn Adams 30/7/24 Bronwyn Adams 30/7/24 Infensa Bioscience selected as a finalist for the 2024 KE Select Emerging Innovator Award by Life Sciences Queensland Read More
Bronwyn Adams 23/5/24 Bronwyn Adams 23/5/24 Infensa CSO and co-founder Professor Glenn King elected a Fellow of the Australian Academy of Science Read More
Bronwyn Adams 5/3/24 Bronwyn Adams 5/3/24 Brisbane startup Infensa spins medical miracle from spider venom Read More
